Your Article Summary
See Latest ArticlesAntiangiogenic strategies for treatment of malignant gliomas
Neurotherapeutics, 07/01/09
Chi AS et al. - A review of antiangiogenic strategies for treatment of malignant gliomas (MG) summarizes clinical experience with antiangiogenic therapy in MG pts, major issues for use and development of these agents, and strategies based on initial gains seen with antiangiogenic agents.
Methods- Review of antiangiogenic strategies for treatment of MG
- Studies are ongoing for numerous antiangiogenic agents with diverse mechanisms of action in treatment of GBM pts
- Early clinical trials suggest that antiangiogenic drugs, which target blood vessels of these highly angiogenic tumors, may have clinical benefit in GBM pts
- Antiangiogenic agents have potent antiedema and steroid-sparing effects; emerging data suggest modest improvement in progression-free survival
- Post-treatment with antiangiogenic agents, a major challenge is interpretation of radiographic changes
- Reliable radiographic and biologic markers are lacking to predict which pts benefit from treatment and accurately indicate response and progression during therapy
- Most pts treated with antiangiogenic drugs eventually progress
Related Articles
MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells
Journal of Neuro-Oncology, 11/04/09
Relevance Score: 68%
Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells
European Journal of Cancer, 11/19/09
Relevance Score: 67%
Methyl-L-11C-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
The Journal of Nuclear Medicine, 11/18/09
Relevance Score: 67%
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Neuro-Oncology, 10/06/09
Relevance Score: 67%
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
Neuro-Oncology, 10/06/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study
Age and Aging, 11/30/09
Pain around the ear in Bell’s palsy is referred pain of facial nerve origin: The role of nervi nervorum
Medical Hypotheses, 11/30/09
Complex Regional Pain Syndrome (CRPS) Impairs Visuospatial Perception, whereas Post-Herpetic Neuralgia does not: Possible Implications for Supraspinal Mechanism of CRPS
Annals, Academy of Medicine, Singapore, 11/29/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Cerebellopontine Angle Tumors in Children: A Single Institution's Experience
Journal of Pediatric Hematology/Oncology, 11/30/09
Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Clinical and Translational Oncology, 11/25/09
Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: A phase II study
Neurosurgery, 11/25/09